Molecular targets in renal tumors: Pathologic assessment

M. Zhou

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Pathologists play critical roles in the clinical management and research of renal cell carcinoma (RCC). Careful assessment by pathologists of a cancer-harboring kidney specimen not only renders an accurate histological diagnosis and classification, but also provides information important for prognosis and therapeutic decisions. In addition, redundant tumor tissues not required for diagnosis could be procured for clinical trials, experimental therapies, and research. This chapter briefly describes how the RCC specimens are processed in pathology laboratories and how clinicians can facilitate such a process. In addition, important pathological and cytogenetic features of different subtypes of RCC will also be discussed.

Original languageEnglish (US)
Title of host publicationRenal Cell Carcinoma
Subtitle of host publicationMolecular Targets and Clinical Applications
PublisherHumana Press
Pages35-48
Number of pages14
ISBN (Print)9781588297372
DOIs
Publication statusPublished - Dec 1 2009

    Fingerprint

Keywords

  • Cytogenetics
  • Pathology
  • Prognosis
  • Renal cell carcinoma
  • Renal neoplasm

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Zhou, M. (2009). Molecular targets in renal tumors: Pathologic assessment. In Renal Cell Carcinoma: Molecular Targets and Clinical Applications (pp. 35-48). Humana Press. https://doi.org/10.1007/978-1-59745-332-5_3